Amanote Research
Register
Sign In
Php31 - Impact of European Medicines Agency (Ema) Clinical Trial Transparency Policies on Health Technology Assessment (Hta) Decisions in Germany
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.927
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
C. Jones
S.L. Cocklin
Publisher
Elsevier BV
Related search
European Medicines Agency Policies for Clinical Trials Leave Women Unprotected
Journal of Epidemiology and Community Health
Epidemiology
Public Health
Occupational Health
Environmental
Pcn22 - Marketing Authorisation Practice of the European Medicines Agency (Ema) in Oncological Indications
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pro Labeling in Products Approved by the European Medicines Agency (EMA) for Narcolepsy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments—A Collaboration Between the European Medicines Agency and the European Network for Health Technology Assessment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
More Transparency for Clinical Trial Data: The Decision by the European Medicines Agency to Make Clinical Trial Reports Publicly Available Could Provide a Boon for Biomedical Research
EMBO Reports
Biochemistry
Genetics
Molecular Biology
Increasing Transparency and the Patient Voice in HTA of New Medicines
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php301 - The Time Is Now for European Hta: How Will the Evolution of European Hta Impact Access to Innovative Medicines?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
European Medicines Agency Workshop on Biosimilar Monoclonal Antibodies
mAbs
Allergy
Immunology
Pcn280 - Impact of Suboptimal Clinical Evidence on Health Technology Assessment Recommendations
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
